{
    "clinical_study": {
        "@rank": "31903", 
        "arm_group": [
            {
                "arm_group_label": "Hypertensive patients", 
                "description": "Hypertensive patients naive to hypertensive treatment"
            }, 
            {
                "arm_group_label": "healthy subjects", 
                "description": "healthy subjects"
            }
        ], 
        "brief_summary": {
            "textblock": "First of all to evaluate the relationship between non-conventional biomarkers and essential\n      hypertension; then to evaluate the effects of various anti-hypertensive drugs on blood\n      pressure control and non-conventional biomarkers in naive hypertensive patients"
        }, 
        "brief_title": "Emerging Biomarkers in Hypertension", 
        "condition": "Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  essential hypertension\n\n          -  naive to treatment\n\n          -  < 65 years\n\n        Exclusion Criteria:\n\n          -  secondary hypertension\n\n          -  previous cardiovascular events"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "64 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with naive essential hypertension aged < 65 years without previous cardiovascular\n        events"
            }
        }, 
        "firstreceived_date": "February 11, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02064218", 
            "org_study_id": "20070002649"
        }, 
        "intervention": {
            "arm_group_label": "Hypertensive patients", 
            "intervention_name": "Anti-hypertensive drugs", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Antihypertensive Agents"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 13, 2014", 
        "location": {
            "contact": {
                "email": "giuseppe.derosa@unipv.it", 
                "last_name": "Giuseppe Derosa, MD, PhD", 
                "phone": "+39 0382 502614"
            }, 
            "facility": {
                "address": {
                    "city": "Pavia", 
                    "country": "Italy", 
                    "zip": "27100"
                }, 
                "name": "IRCCS Policlinico S.Matteo Foundation"
            }, 
            "investigator": {
                "last_name": "Pamela Maffioli, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "2", 
        "official_title": "Evaluation of Some Emerging Biomarkers of Cardiovascular Risk Stratification in Hypertensive Patients: a 5-years Follow-up", 
        "other_outcome": {
            "description": "- Aortic Pulse Wave velocity (PWV)", 
            "measure": "Evaluation of vascular stiffness", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "overall_contact": {
            "email": "giuseppe.derosa@unipv.it", 
            "last_name": "Giuseppe Derosa, MD, PhD", 
            "phone": "+39 0382 502614"
        }, 
        "overall_contact_backup": {
            "email": "amedeo.mugellini@unipv.it", 
            "last_name": "Amedeo Mugellini, MD, PhD", 
            "phone": "+39 0382 502614"
        }, 
        "overall_official": {
            "affiliation": "University of Pavia", 
            "last_name": "Giuseppe Derosa, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Systolic Blood Pressure (SBP)\nDiastolic Blood Pressure (DBP)", 
            "measure": "Blood pressure reduction", 
            "safety_issue": "Yes", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02064218"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Pavia", 
            "investigator_full_name": "Giuseppe Derosa", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Lipoprotein (a) (Lp(a))\nsRAGE (soluble Receptor for Advanced Glycation End-products)\nsCD40L (soluble ligand of CD40)\nMPO (myeloperoxidase)", 
            "measure": "Cardiovascular and metabolic biomarkers", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "source": "University of Pavia", 
        "sponsors": {
            "collaborator": {
                "agency": "IRCCS Policlinico S. Matteo Foundation", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Pavia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2007", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2007"
    }
}